This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Albert Einstein College of Medicine, Drive Therapeutics LLC. Active years: 2026.
Company Filing History:
1 out of 513 
1 out of 2 Years Active: 2026
Title: The Innovations of Derek Parks
Introduction
Derek Parks is an accomplished inventor based in Raleigh, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of compositions and methods that inhibit vascular endothelial growth factor. His innovative work has led to the granting of a patent, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Derek Parks holds a patent for "STEM-LOOP COMPOSITIONS AND METHODS FOR INHIBITING VASCULAR ENDOTHELIAL GROWTH FACTOR." This patent represents his commitment to finding solutions that can potentially impact therapeutic approaches in treating various conditions.
Career Highlights
Throughout his career, Derek has worked with notable organizations, including Drive Therapeutics LLC and Albert Einstein College of Medicine. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Derek has had the opportunity to work alongside talented individuals such as Carl Erickson and Christopher P. Rusconi. These collaborations have enriched his professional journey and fostered an environment of innovation and creativity.
Conclusion
Derek Parks exemplifies the spirit of innovation through his patent and collaborative efforts in the biotechnology sector. His work continues to inspire advancements in medical research and therapeutic development.